Dhananjay Singh assumes role of MD of Merck Life Science in India
Merck India has said that Dhananjay Singh has assumed the role of Managing Director of Merck Life Science in India, alongside his current position as Head of Science & Lab Solutions Commercial, India.
Effective April 1, 2024, Singh succeeded Sreenath NS, who retired after serving Merck in India for 36 years, according to a company statement.
In his new role, Singh will be responsible for driving Life Science strategy in India, ensuring governance and compliance in collaboration with other Merck business leaders in the country.
"As an expert with 26 years with Merck, Dhananjay has been instrumental in shaping the Science and Lab Solutions Commercial business in India and is exemplary in his commitment to advancing scientific progress in partnership with our customers," Merck India Country Speaker Pratima Reddy was quoted as saying by PTI.
Reddy further noted that Singh's deep understanding of market dynamics and multi-stakeholder relationship management will bolster Merck Life Science's presence in the Indian market.
Singh began his journey with Sigma-Aldrich in 1997 and has held various leadership roles within the Commercial Organisation. He assumed the position of Head of Science & Lab Solutions Commercial for India in 2022, before his recent appointment as Managing Director for Merck Life Science in India.
Read also: Aurobindo Pharma appoints T Vijaya Kumar as President - RnD (Specialty Drug Delivery)
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd